The document discusses ongoing research into understanding the human microbiome and its role in health and disease. It outlines how sequencing costs have dropped dramatically, enabling analysis of both human and microbial genomes. Several studies are highlighted that use microbiome profiling to differentiate between healthy individuals and those with various forms of inflammatory bowel disease.